A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma
Clinical trial NCT02905266 · COMPLETED
Trial details
- NCT number
- NCT02905266
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-27
- Primary completion
- 2017-10-23
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.